Search research articles
Contact Us
Filters
Showing results (31-40 of 497) with videos related to
Page
of 50
Sort By:
JAMA Oncology
|
December 19, 2024
Assessing the Risk of Radiation Myelitis in Hypofractionated Stereotactic Body Radiation Therapy-Tolerance Is in the Eye of the Beholder
Evangelia Katsoulakis, Daniel E Spratt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2016
Comparing Two Multifraction Spine Radiotherapy Regimens: Are They Really Equivalent?
Daniel E Spratt, Nicholas Szerlip
International Journal of Radiation Oncology, Biology, Physics
|
February 25, 2026
Continuing the Focal Fallacy
Jonathan Shoag, Daniel E Spratt
Brachytherapy
|
August 31, 2013
Point: There is a need for supplemental XRT with brachytherapy in the treatment of intermediate-risk prostate cancer patients
Daniel E Spratt, Michael J Zelefsky
International Journal of Radiation Oncology, Biology, Physics
|
May 15, 2022
Bicalutamide Monotherapy With Radiation Therapy for Localized Prostate Cancer: A Non-Evidence-Based Alternative
Angela Y Jia, Daniel E Spratt
European Urology
|
November 13, 2016
Reply to Filippo Alongi, Rosario Mazzola, Dario Aiello and Matteo Salgarello's Letter to the Editor re: Re: Daniel E. Spratt, Hebert A. Vargas, Zachary S. Zumsteg, et al. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage. Eur Urol 2017;71:37-43. A Step Forward in the Era of Functional Imaging?: Functional Imaging and Micrometastatic Disease: Implications for Radiotherapy Field Design
Daniel E Spratt, Michael J Zelefsky
The Lancet. Oncology
|
October 3, 2024
A step closer to the use of [<sup>177</sup>Lu]Lu-PSMA-617 in metastatic hormone-sensitive prostate cancer
Angela Y Jia, Daniel E Spratt
International Journal of Radiation Oncology, Biology, Physics
|
June 18, 2019
Long-Term Benefits of Dose-Escalation in Localized Prostate Cancer
Daniel E Spratt, Jeff M Michalski
Prostate Cancer and Prostatic Diseases
|
December 16, 2022
Radiotherapy in patients with node-positive prostate cancer after radical prostatectomy
Angela Y Jia, Daniel E Spratt
The Lancet. Oncology
|
October 2, 2025
Revisiting prostate cancer active surveillance candidacy
Daniel E Spratt, Edward M Schaeffer
Page
of 50
Search research articles
Search
Showing results (31-40 of 497) with videos related to
Sort By:
Page
of 50
JAMA Oncology
|
December 19, 2024
Assessing the Risk of Radiation Myelitis in Hypofractionated Stereotactic Body Radiation Therapy-Tolerance Is in the Eye of the Beholder
Evangelia Katsoulakis, Daniel E Spratt
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2016
Comparing Two Multifraction Spine Radiotherapy Regimens: Are They Really Equivalent?
Daniel E Spratt, Nicholas Szerlip
International Journal of Radiation Oncology, Biology, Physics
|
February 25, 2026
Continuing the Focal Fallacy
Jonathan Shoag, Daniel E Spratt
Brachytherapy
|
August 31, 2013
Point: There is a need for supplemental XRT with brachytherapy in the treatment of intermediate-risk prostate cancer patients
Daniel E Spratt, Michael J Zelefsky
International Journal of Radiation Oncology, Biology, Physics
|
May 15, 2022
Bicalutamide Monotherapy With Radiation Therapy for Localized Prostate Cancer: A Non-Evidence-Based Alternative
Angela Y Jia, Daniel E Spratt
European Urology
|
November 13, 2016
Reply to Filippo Alongi, Rosario Mazzola, Dario Aiello and Matteo Salgarello's Letter to the Editor re: Re: Daniel E. Spratt, Hebert A. Vargas, Zachary S. Zumsteg, et al. Patterns of Lymph Node Failure after Dose-escalated Radiotherapy: Implications for Extended Pelvic Lymph Node Coverage. Eur Urol 2017;71:37-43. A Step Forward in the Era of Functional Imaging?: Functional Imaging and Micrometastatic Disease: Implications for Radiotherapy Field Design
Daniel E Spratt, Michael J Zelefsky
The Lancet. Oncology
|
October 3, 2024
A step closer to the use of [<sup>177</sup>Lu]Lu-PSMA-617 in metastatic hormone-sensitive prostate cancer
Angela Y Jia, Daniel E Spratt
International Journal of Radiation Oncology, Biology, Physics
|
June 18, 2019
Long-Term Benefits of Dose-Escalation in Localized Prostate Cancer
Daniel E Spratt, Jeff M Michalski
Prostate Cancer and Prostatic Diseases
|
December 16, 2022
Radiotherapy in patients with node-positive prostate cancer after radical prostatectomy
Angela Y Jia, Daniel E Spratt
The Lancet. Oncology
|
October 2, 2025
Revisiting prostate cancer active surveillance candidacy
Daniel E Spratt, Edward M Schaeffer
Page
of 50